nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzonatate—Nonoxynol-9—PTGS2—melanoma	0.129	1	CrCbGaD
Benzonatate—SCN5A—Interaction between L1 and Ankyrins—SCN11A—melanoma	0.0951	0.136	CbGpPWpGaD
Benzonatate—SCN5A—Interaction between L1 and Ankyrins—SCN10A—melanoma	0.0546	0.0783	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—SCN11A—melanoma	0.0365	0.0523	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—NODAL—melanoma	0.0287	0.0411	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—DCX—melanoma	0.0253	0.0363	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—POU3F2—melanoma	0.0248	0.0355	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—SCN10A—melanoma	0.021	0.0301	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—PAX6—melanoma	0.018	0.0258	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—CXCR4—melanoma	0.0159	0.0228	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—MAP2—melanoma	0.0142	0.0204	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—PLXNC1—melanoma	0.0138	0.0198	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—SCN11A—melanoma	0.0138	0.0198	CbGpPWpGaD
Benzonatate—Eruption—Dactinomycin—melanoma	0.0129	0.0745	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—TP73—melanoma	0.0121	0.0173	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—melanoma	0.0115	0.0165	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—SCN11A—melanoma	0.00985	0.0141	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—DRAP1—melanoma	0.00985	0.0141	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PLXNC1—melanoma	0.00985	0.0141	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—KDR—melanoma	0.00971	0.0139	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—DCX—melanoma	0.00956	0.0137	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—melanoma	0.00915	0.0131	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—ITGAV—melanoma	0.00902	0.0129	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—KIT—melanoma	0.00894	0.0128	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—EPHA2—melanoma	0.00889	0.0127	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—IGF1—melanoma	0.00819	0.0117	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—ITGB1—melanoma	0.00819	0.0117	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—SCN10A—melanoma	0.00793	0.0114	CbGpPWpGaD
Benzonatate—Eruption—Docetaxel—melanoma	0.00778	0.0448	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—FGF2—melanoma	0.00753	0.0108	CbGpPWpGaD
Benzonatate—Depressed level of consciousness—Carmustine—melanoma	0.00719	0.0414	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—ITGB3—melanoma	0.0071	0.0102	CbGpPWpGaD
Benzonatate—Depressed level of consciousness—Temozolomide—melanoma	0.00695	0.04	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—MAP2K2—melanoma	0.00694	0.00995	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—DCX—melanoma	0.00683	0.00978	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—RAC1—melanoma	0.00658	0.00943	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—EPHA2—melanoma	0.00635	0.00909	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PAX4—melanoma	0.00635	0.00909	CbGpPWpGaD
Benzonatate—Nasal congestion—Temozolomide—melanoma	0.00574	0.033	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—SCN10A—melanoma	0.00566	0.00811	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—RHOB—melanoma	0.00561	0.00804	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—DCC—melanoma	0.00555	0.00795	CbGpPWpGaD
Benzonatate—Bronchospasm—Bleomycin—melanoma	0.00527	0.0303	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—IL10—melanoma	0.00508	0.00728	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—RAC2—melanoma	0.00502	0.0072	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—MAP2K1—melanoma	0.00492	0.00705	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NODAL—melanoma	0.00481	0.00689	CbGpPWpGaD
Benzonatate—Constipation—Vemurafenib—melanoma	0.0043	0.0247	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—HIF1A—melanoma	0.00428	0.00613	CbGpPWpGaD
Benzonatate—Hypoaesthesia—Bleomycin—melanoma	0.00426	0.0245	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—RHOB—melanoma	0.004	0.00573	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—DCC—melanoma	0.00396	0.00568	CbGpPWpGaD
Benzonatate—Hypoaesthesia—Carmustine—melanoma	0.00372	0.0214	CcSEcCtD
Benzonatate—Hypersensitivity—Vemurafenib—melanoma	0.0037	0.0213	CcSEcCtD
Benzonatate—Hypoaesthesia—Temozolomide—melanoma	0.0036	0.0207	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—RAC2—melanoma	0.00359	0.00514	CbGpPWpGaD
Benzonatate—Pruritus—Vemurafenib—melanoma	0.00356	0.0205	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—CDH2—melanoma	0.00343	0.00491	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—ITGAV—melanoma	0.00341	0.00488	CbGpPWpGaD
Benzonatate—Dizziness—Vemurafenib—melanoma	0.00332	0.0191	CcSEcCtD
Benzonatate—Rash—Vemurafenib—melanoma	0.00317	0.0182	CcSEcCtD
Benzonatate—Headache—Vemurafenib—melanoma	0.00315	0.0181	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—MAPK3—melanoma	0.00315	0.00451	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—ITGB1—melanoma	0.00309	0.00443	CbGpPWpGaD
Benzonatate—Confusional state—Bleomycin—melanoma	0.00307	0.0177	CcSEcCtD
Benzonatate—Tremor—Carmustine—melanoma	0.00305	0.0176	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—PAX6—melanoma	0.00302	0.00432	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—MAPK1—melanoma	0.00299	0.00429	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—EGFR—melanoma	0.00299	0.00429	CbGpPWpGaD
Benzonatate—Agitation—Carmustine—melanoma	0.00299	0.0172	CcSEcCtD
Benzonatate—Nausea—Vemurafenib—melanoma	0.00298	0.0172	CcSEcCtD
Benzonatate—Bronchospasm—Docetaxel—melanoma	0.00295	0.017	CcSEcCtD
Benzonatate—Tremor—Temozolomide—melanoma	0.00295	0.017	CcSEcCtD
Benzonatate—Agitation—Temozolomide—melanoma	0.00289	0.0166	CcSEcCtD
Benzonatate—Convulsion—Carmustine—melanoma	0.00282	0.0162	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CXCL8—melanoma	0.00278	0.00398	CbGpPWpGaD
Benzonatate—Convulsion—Temozolomide—melanoma	0.00273	0.0157	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—ITGB3—melanoma	0.00268	0.00385	CbGpPWpGaD
Benzonatate—Confusional state—Carmustine—melanoma	0.00268	0.0154	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CASP3—melanoma	0.00266	0.00381	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MAP2K2—melanoma	0.00262	0.00376	CbGpPWpGaD
Benzonatate—Confusional state—Temozolomide—melanoma	0.00259	0.0149	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.00256	0.00367	CbGpPWpGaD
Benzonatate—Feeling abnormal—Bleomycin—melanoma	0.00251	0.0144	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—RAC1—melanoma	0.00249	0.00356	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—NFKB1—melanoma	0.00248	0.00356	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ITGAV—melanoma	0.00243	0.00349	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—AKT3—melanoma	0.00243	0.00349	CbGpPWpGaD
Benzonatate—Hypoaesthesia—Docetaxel—melanoma	0.00239	0.0138	CcSEcCtD
Benzonatate—Feeling abnormal—Dactinomycin—melanoma	0.00234	0.0135	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—KDR—melanoma	0.00228	0.00327	CbGpPWpGaD
Benzonatate—Constipation—Carmustine—melanoma	0.00227	0.0131	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—VEGFA—melanoma	0.00226	0.00323	CbGpPWpGaD
Benzonatate—Hypersensitivity—Bleomycin—melanoma	0.00224	0.0129	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—MET—melanoma	0.00223	0.0032	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ITGB1—melanoma	0.00221	0.00316	CbGpPWpGaD
Benzonatate—Constipation—Temozolomide—melanoma	0.0022	0.0126	CcSEcCtD
Benzonatate—Feeling abnormal—Carmustine—melanoma	0.00219	0.0126	CcSEcCtD
Benzonatate—Pruritus—Bleomycin—melanoma	0.00215	0.0124	CcSEcCtD
Benzonatate—Feeling abnormal—Temozolomide—melanoma	0.00212	0.0122	CcSEcCtD
Benzonatate—Hypersensitivity—Dactinomycin—melanoma	0.00209	0.012	CcSEcCtD
Benzonatate—Hypersensitivity—Carmustine—melanoma	0.00196	0.0113	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—TNF—melanoma	0.00193	0.00277	CbGpPWpGaD
Benzonatate—Rash—Bleomycin—melanoma	0.00192	0.0111	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—ITGB3—melanoma	0.00191	0.00274	CbGpPWpGaD
Benzonatate—Hypersensitivity—Temozolomide—melanoma	0.00189	0.0109	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—MAP2K2—melanoma	0.00187	0.00268	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MMP2—melanoma	0.00186	0.00267	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MAP2K1—melanoma	0.00186	0.00267	CbGpPWpGaD
Benzonatate—Pruritus—Temozolomide—melanoma	0.00182	0.0105	CcSEcCtD
Benzonatate—Convulsion—Docetaxel—melanoma	0.00181	0.0104	CcSEcCtD
Benzonatate—Nausea—Bleomycin—melanoma	0.00181	0.0104	CcSEcCtD
Benzonatate—Rash—Dactinomycin—melanoma	0.00179	0.0103	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—RAC1—melanoma	0.00177	0.00254	CbGpPWpGaD
Benzonatate—Dizziness—Carmustine—melanoma	0.00176	0.0101	CcSEcCtD
Benzonatate—Confusional state—Docetaxel—melanoma	0.00172	0.00991	CcSEcCtD
Benzonatate—Dizziness—Temozolomide—melanoma	0.0017	0.00978	CcSEcCtD
Benzonatate—Nausea—Dactinomycin—melanoma	0.00169	0.00971	CcSEcCtD
Benzonatate—Shock—Docetaxel—melanoma	0.00168	0.00967	CcSEcCtD
Benzonatate—Rash—Carmustine—melanoma	0.00168	0.00965	CcSEcCtD
Benzonatate—Headache—Carmustine—melanoma	0.00166	0.00958	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—ERBB2—melanoma	0.00163	0.00234	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—KDR—melanoma	0.00163	0.00233	CbGpPWpGaD
Benzonatate—Rash—Temozolomide—melanoma	0.00162	0.00932	CcSEcCtD
Benzonatate—Headache—Temozolomide—melanoma	0.00161	0.00926	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—CDK4—melanoma	0.00159	0.00228	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MET—melanoma	0.00159	0.00228	CbGpPWpGaD
Benzonatate—Nausea—Carmustine—melanoma	0.00158	0.00909	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—IL6—melanoma	0.00156	0.00224	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NOTCH1—melanoma	0.00153	0.0022	CbGpPWpGaD
Benzonatate—Nausea—Temozolomide—melanoma	0.00153	0.00878	CcSEcCtD
Benzonatate—Constipation—Docetaxel—melanoma	0.00146	0.00841	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—PPARG—melanoma	0.00145	0.00207	CbGpPWpGaD
Benzonatate—Feeling abnormal—Docetaxel—melanoma	0.00141	0.0081	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—MMP9—melanoma	0.0014	0.00201	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MMP2—melanoma	0.00133	0.0019	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MAP2K1—melanoma	0.00133	0.0019	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—FGF2—melanoma	0.00126	0.00181	CbGpPWpGaD
Benzonatate—Hypersensitivity—Docetaxel—melanoma	0.00126	0.00724	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—VEGFA—melanoma	0.00126	0.0018	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—NRAS—melanoma	0.00124	0.00178	CbGpPWpGaD
Benzonatate—Pruritus—Docetaxel—melanoma	0.00121	0.00696	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—MAPK3—melanoma	0.00119	0.0017	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ERBB2—melanoma	0.00116	0.00167	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MAPK1—melanoma	0.00113	0.00162	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—EGFR—melanoma	0.00113	0.00162	CbGpPWpGaD
Benzonatate—Dizziness—Docetaxel—melanoma	0.00113	0.0065	CcSEcCtD
Benzonatate—Rash—Docetaxel—melanoma	0.00108	0.0062	CcSEcCtD
Benzonatate—Headache—Docetaxel—melanoma	0.00107	0.00616	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—KRAS—melanoma	0.00107	0.00153	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—CTNNB1—melanoma	0.00102	0.00146	CbGpPWpGaD
Benzonatate—Nausea—Docetaxel—melanoma	0.00101	0.00584	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—MMP9—melanoma	0.000999	0.00143	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NFKB1—melanoma	0.000988	0.00142	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—HRAS—melanoma	0.000908	0.0013	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—VEGFA—melanoma	0.000897	0.00129	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—STAT3—melanoma	0.000888	0.00127	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NRAS—melanoma	0.000886	0.00127	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—IL6—melanoma	0.000869	0.00125	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MAPK3—melanoma	0.000848	0.00122	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MAPK1—melanoma	0.000807	0.00116	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—EGFR—melanoma	0.000807	0.00116	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—TNF—melanoma	0.000769	0.0011	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—KRAS—melanoma	0.000762	0.00109	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HRAS—melanoma	0.000648	0.000929	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—IL6—melanoma	0.00062	0.000889	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—AKT1—melanoma	0.000572	0.00082	CbGpPWpGaD
